BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17942775)

  • 21. Hemodialysis catheter-associated fibrin sheaths: treatment with a low-dose rt-PA infusion.
    Savader SJ; Haikal LC; Ehrman KO; Porter DJ; Oteham AC
    J Vasc Interv Radiol; 2000 Oct; 11(9):1131-6. PubMed ID: 11041468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrin sheath and its relation to subsequent events after tunneled dialysis catheter exchange.
    Shanaah A; Brier M; Dwyer A
    Semin Dial; 2013; 26(6):733-7. PubMed ID: 23441925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrin sheath stripping versus catheter exchange for the treatment of failed tunneled hemodialysis catheters: randomized clinical trial.
    Merport M; Murphy TP; Egglin TK; Dubel GJ
    J Vasc Interv Radiol; 2000 Oct; 11(9):1115-20. PubMed ID: 11041466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Change in vascular access and mortality in maintenance hemodialysis patients.
    Lacson E; Wang W; Lazarus JM; Hakim RM
    Am J Kidney Dis; 2009 Nov; 54(5):912-21. PubMed ID: 19748717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
    Schumm K; Lam TB
    Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Clinical Performance of VectorFlow and Palindrome Symmetric-Tip Dialysis Catheters: A Multicenter, Randomized Trial.
    Nadolski GJ; Redmond J; Shin B; Shamimi-Noori S; Vance A; Hammelman B; Clark TWI; Cohen R; Rudnick M
    J Vasc Interv Radiol; 2020 Jul; 31(7):1148-1155. PubMed ID: 32534972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urokinase efficacy in the restoration of hemodialysis catheter function.
    Meers C; Toffelmire EB
    J CANNT; 1998; 8(2):17-9. PubMed ID: 9807329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
    Pellicano R; Polkinghorne KR; Kerr PG
    Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endovascular dialysis interventions in the era of DOQI.
    Greenberg JI; Suliman A; Angle N
    Ann Vasc Surg; 2008 Sep; 22(5):657-62. PubMed ID: 18619775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-cuffed dual lumen catheters in the external jugular veins versus other central veins for hemodialysis patients.
    Moini M; Rasouli MR; Kenari MM; Mahmoodi HR
    Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):44-8. PubMed ID: 19112218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enoxaparin inhibits fibrin sheath formation and decreases central venous catheter colonization following bacteremic challenge.
    Keller JE; Hindman JW; Mehall JR; Smith SD
    Crit Care Med; 2006 May; 34(5):1450-5. PubMed ID: 16540961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conversion of vascular access type among incident hemodialysis patients: description and association with mortality.
    Bradbury BD; Chen F; Furniss A; Pisoni RL; Keen M; Mapes D; Krishnan M
    Am J Kidney Dis; 2009 May; 53(5):804-14. PubMed ID: 19268411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measuring of the heparin leakage into the circulation from central venous catheters--an in vivo study.
    Markota I; Markota D; Tomic M
    Nephrol Dial Transplant; 2009 May; 24(5):1550-3. PubMed ID: 19075195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcome of the Tal Palindrome chronic hemodialysis catheter: single institution experience.
    Spector M; Mojibian H; Eliseo D; Pollak JS; Reiner E; Arici M; Tal MG
    J Vasc Interv Radiol; 2008 Oct; 19(10):1434-8. PubMed ID: 18693044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of intravenous electrocardiography for insertion of central veins dialysis catheters.
    Beigi AA; Parvizian F; Masoudpour H
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):794-7. PubMed ID: 19736475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endovascular treatment of stenosis of autogenous arteriovenous access for hemodialysis.
    Kipiani VK; Parkosadze GL; Gogorishvili IR; Urushadze OP; Kipiani KB; Kipshidze NN
    Georgian Med News; 2009 Jan; (166):13-7. PubMed ID: 19202210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malfunction of dialysis catheters: management of fibrin sheath and related problems.
    Faintuch S; Salazar GM
    Tech Vasc Interv Radiol; 2008 Sep; 11(3):195-200. PubMed ID: 19100950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue plasminogen activator as a hemodialysis catheter locking solution.
    McGill RL; Spero JA; Sysak JC; Sandroni SE; Marcus RJ
    Hemodial Int; 2008 Jul; 12(3):348-51. PubMed ID: 18638092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of air emboli during central venous access: do "protective" sheaths or insertion techniques matter?
    Kolbeck KJ; Itkin M; Stavropoulos SW; Trerotola SO
    J Vasc Interv Radiol; 2005 Jan; 16(1):89-99. PubMed ID: 15640415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Catheter Replacement Methods in Hemodialysis Patients With Dysfunctional Tunneled-Cuffed Catheters With Fibrin Sheaths].
    Jin L; Wang H; Cui T; Liao R
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1283-1287. PubMed ID: 38162080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.